Reversible thyroid dysfunction during treatment with GM-CSF
- 1 August 1991
- journal article
- Published by Elsevier in The Lancet
- Vol. 338 (8766) , 541-542
- https://doi.org/10.1016/0140-6736(91)91103-2
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Effects of Interferon-γ Therapy on Thyroid Function, T-Lymphocyte Subpopulations and Induction of AutoantibodiesJournal of Clinical Endocrinology & Metabolism, 1990
- Induction of Human Thyroid Cell ICAM-1 (CD54) Antigen Expression and ICAM-1-Mediated Lymphocyte Binding*Endocrinology, 1990
- Granulocyte-macrophage colony-stimulating factor stimulates human monocyte accessory cell function.The Journal of Immunology, 1990
- Dendritic cells and class II MHC expression on thyrocytes during the autoimmune thyroid disease of the BB ratClinical Immunology and Immunopathology, 1990
- Granulocyte-macrophage colony-stimulating factor promotes differentiation and survival of human peripheral blood dendritic cells in vitro.Journal of Clinical Investigation, 1990
- Correction of granulocytopenia in Felty's syndrome by granulocyte- macrophage colony-stimulating factor. Simultaneous induction of interleukin-6 release and flare-up of the arthritisBlood, 1989
- Effects of Bacterially Synthesized Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor in Patients with Advanced MalignancyAnnals of Internal Medicine, 1989
- Hypothyroidism after Treatment with Interleukin-2 and Lymphokine-Activated Killer CellsNew England Journal of Medicine, 1988
- Thyroid Autoimmunity in Patients on Long Term Therapy with Leukocyte-Derived Interferon*Journal of Clinical Endocrinology & Metabolism, 1986
- Thein VitroRegulation of Human Thyrocyte HLA-DR Antigen Expression*Journal of Clinical Endocrinology & Metabolism, 1985